Aggressive treatment is essential to reduce cardiovascular risk in diabetic hypertensive patients

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.26, Iss.1, 2010-01, pp. : 8-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins may reduce CHD risk in non-dyslipidaemic hypertensive patients

By  

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Cardiovascular Risk in Obese Hypertensive Patients Taking Various Antihypertensive Drugs

By Schindler Christoph  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 707-717

Adis International

Access to resources Recommend Favorite

Effects of Chronic Treatment with Lisinopril on Cardiovascular Complications in Streptozotocin Diabetic and Doca Hypertensive Rats

By Sevak A.R.   Goyal R.K.  

Pharmacological Research, Vol. 34, Iss. 5, 1996-11 ,pp. : 201-209

Academic Press

Access to resources Recommend Favorite

Microalbuminuria in Thai Essential Hypertensive Patients

By Buranakitjaroen P   Phoojaroenchanachai M   Saravich S  

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 836-847

Field House Publishing

Access to resources Recommend Favorite

Efficacy and Tolerability of Long-Term Rilmenidine Treatment in Hypertensive Diabetic Patients: A Retrospective Analysis of a General Practice Study

By Meredith P.A.   Reid J.L.  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 3, 2004-01 ,pp. : 195-200

Adis International

Access to resources Recommend Favorite